Literature DB >> 18565692

Dopamine transporter levels in cocaine dependent subjects.

Paul Crits-Christoph1, Andrew Newberg, Nancy Wintering, Karl Ploessl, Mary Beth Connolly Gibbons, Sarah Ring-Kurtz, Robert Gallop, Julie Present.   

Abstract

Cocaine use is a significant problem in the US and it is well established that cocaine binds to the dopamine transporter (DAT) in the brain. This study was designed to determine if the DAT levels measured by 99mTc TRODAT SPECT (single photon emission computed tomography) brain scans are altered in cocaine dependent subjects and to explore clinical correlates of such alterations. SPECT brain scans were acquired on 21 cocaine dependent subjects and 21 healthy matched controls. There were significantly higher DAT levels in cocaine dependent subjects compared to controls for the anterior putamen (p=0.003; Cohen's d effect size=0.98), posterior putamen (p<0.001; effect size=1.32), and caudate (p=0.003; effect size=0.97). DAT levels in these regions were 10%, 17%, and 8% higher in the cocaine dependent subjects compared to controls. DAT levels were unrelated to craving, severity of cocaine use, or duration of cocaine use, but DAT levels in the caudate and anterior putamen were significantly (p<0.05) negatively correlated with days since last use of cocaine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18565692      PMCID: PMC2564619          DOI: 10.1016/j.drugalcdep.2008.04.014

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  39 in total

Review 1.  Structure and function of the dopamine transporter.

Authors:  N Chen; M E Reith
Journal:  Eur J Pharmacol       Date:  2000-09-29       Impact factor: 4.432

2.  Simplified quantification of dopamine transporters in humans using [99mTc]TRODAT-1 and single-photon emission tomography.

Authors:  P D Acton; P T Meyer; P D Mozley; K Plössl; H F Kung
Journal:  Eur J Nucl Med       Date:  2000-11

3.  Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients.

Authors:  L K Jacobsen; J K Staley; R T Malison; S S Zoghbi; J P Seibyl; T R Kosten; R B Innis
Journal:  Am J Psychiatry       Date:  2000-07       Impact factor: 18.112

4.  Measurement of the striatal dopamine transporter density and heterogeneity in type 1 alcoholics using human whole hemisphere autoradiography.

Authors:  E Tupala; J T Kuikka; H Hall; K Bergström; T Särkioja; P Räsänen; T Mantere; J Hiltunen; J Vepsäläinen; J Tiihonen
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

5.  Individual and combined effects of ethanol and cocaine on the human dopamine transporter in neuronal cell lines.

Authors:  M Ho; M Segre
Journal:  Neurosci Lett       Date:  2001-02-23       Impact factor: 3.046

6.  Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.

Authors:  S R Letchworth; M A Nader; H R Smith; D P Friedman; L J Porrino
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

7.  Terminal effects of ethanol on dopamine dynamics in rat nucleus accumbens: an in vitro voltammetric study.

Authors:  E A Budygin; P E Phillips; R M Wightman; S R Jones
Journal:  Synapse       Date:  2001-11       Impact factor: 2.562

8.  RTI-76, an irreversible inhibitor of dopamine transporter binding, increases locomotor activity in the rat at high doses.

Authors:  H L Kimmel; F I Carroll; M J Kuhar
Journal:  Brain Res       Date:  2001-04-06       Impact factor: 3.252

9.  Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.

Authors:  R T Malison; S E Best; C H van Dyck; E F McCance; E A Wallace; M Laruelle; R M Baldwin; J P Seibyl; L H Price; T R Kosten; R B Innis
Journal:  Am J Psychiatry       Date:  1998-06       Impact factor: 18.112

10.  A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls.

Authors:  Jay D Amsterdam; Andrew B Newberg
Journal:  Neuropsychobiology       Date:  2007-07-26       Impact factor: 2.328

View more
  15 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Alterations in adult behavioral responses to cocaine and dopamine transporters following juvenile exposure to methamphetamine.

Authors:  Lisa McFadden; Bryan K Yamamoto; Leslie Matuszewich
Journal:  Behav Brain Res       Date:  2010-09-09       Impact factor: 3.332

3.  Identification of a Vav2-dependent mechanism for GDNF/Ret control of mesolimbic DAT trafficking.

Authors:  Shuyong Zhu; Chengjiang Zhao; Yingying Wu; Qiaoqiao Yang; Aiyun Shao; Tiepeng Wang; Jianfu Wu; Yanqing Yin; Yandong Li; Jincan Hou; Xinhua Zhang; Guomin Zhou; Xiaosong Gu; Xiaomin Wang; Xosé R Bustelo; Jiawei Zhou
Journal:  Nat Neurosci       Date:  2015-07-06       Impact factor: 24.884

4.  Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99m)Tc]TRODAT-1.

Authors:  Marcelo Q Hoexter; Gustavo Fadel; André C Felício; Mariana B Calzavara; Ilza R Batista; Marilia A Reis; Ming C Shih; Roger K Pitman; Sérgio B Andreoli; Marcelo F Mello; Jair J Mari; Rodrigo A Bressan
Journal:  Psychopharmacology (Berl)       Date:  2012-06-15       Impact factor: 4.530

5.  Dopamine transporter trafficking: rapid response on demand.

Authors:  Rong Chen; Cheryse A Furman; Margaret E Gnegy
Journal:  Future Neurol       Date:  2010-01-01

Review 6.  Imaging receptor changes in human drug abusers.

Authors:  Kelly P Cosgrove
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 7.  Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.

Authors:  Christopher L German; Michelle G Baladi; Lisa M McFadden; Glen R Hanson; Annette E Fleckenstein
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

8.  Hyperdopaminergic tone in HIV-1 protein treated rats and cocaine sensitization.

Authors:  Mark J Ferris; Danielle Frederick-Duus; Jim Fadel; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurochem       Date:  2010-10-05       Impact factor: 5.372

Review 9.  A targeted review of the neurobiology and genetics of behavioural addictions: an emerging area of research.

Authors:  Robert F Leeman; Marc N Potenza
Journal:  Can J Psychiatry       Date:  2013-05       Impact factor: 4.356

Review 10.  Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.

Authors:  Abhishekh H Ashok; Yuya Mizuno; Nora D Volkow; Oliver D Howes
Journal:  JAMA Psychiatry       Date:  2017-05-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.